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Abstract
The basic concept of conditionally replicating adenoviruses (CRAD) as oncolytic agents is that progenies generated from
each round of infection will disperse, infect and kill new cancer cells. However, CRAD has only inhibited, but not eradicated
tumor growth in xenograft tumor therapy, and CRAD therapy has had only marginal clinical benefit to cancer patients. Here,
we found that CRAD propagation and cancer cell survival co-existed for long periods of time when infection was initiated at
low multiplicity of infection (MOI), and cancer cell killing was inefficient and slow compared to the assumed cell killing effect
upon infection at high MOI. Excessive production of fiber molecules from initial CRAD infection of only 1 to 2% cancer cells
and their release prior to the viral particle itself caused a tropism-specific receptor masking in both infected and non-
infected bystander cells. Consequently, the non-infected bystander cells were inefficiently bound and infected by CRAD
progenies. Further, fiber overproduction with concomitant restriction of adenovirus spread was observed in xenograft
cancer therapy models. Besides the CAR-binding Ad4, Ad5, and Ad37, infection with CD46-binding Ad35 and Ad11 also
caused receptor masking. Fiber overproduction and its resulting receptor masking thus play a key role in limiting CRAD
functionality, but potentially promote adenovirus and host cell co-existence. These findings also give important clues for
understanding mechanisms underlying the natural infection course of various adenoviruses.
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Introduction
Adenovirus infections are endemic in all human populations
regardless the quality of their health standards. Although
adenovirus infections can be persistent or latent, they are mostly
acute or self-limiting [1,2]. As acute adenovirus infection results in
cell lysis, serotype 5 adenovirus (Ad5) based conditionally
replicating adenoviruses (CRAD) have been developed as
oncolytic agents [3]. The CRADs have been engineered either
by controlling E1A expression via cancer cell specific promoters,
or by deletion of adenoviral gene functions essential for viral
replication in normal cells but not in tumor cells [3]. A large
number of cell culture and xenograft tumor model studies have
shown the potential power of CRAD in cancer therapy. However,
successful translation of these promising pre-clinical results to the
benefit of cancer patients remains elusive [4].
Various strategies have been applied to improve the cancer cell
killing capacity of CRAD. For example, more stringent cancer cell
specific promoters have been utilized to control E1A expression for
improved specificity of CRAD replication in cancer cells [5–7].
Binding of adenovirus fiber proteins to host cell receptors is the
very first step in initiating adenoviral infection in many cell types,
and critically determines whether a given cell type is permissive to
adenovirus infection. So by fiber re-targeting, novel tropism has
been engineered in CRAD, enabling CRAD to infect different/
multiple types of cancer cells [8,9]. However, a key challenge in
utilizing CRADs as cancer therapy agents appears to be their
inefficient spreading capacity which limits infection propagation
[10,11]. Also, as most individuals have neutralizing antibodies
against Ad5, CRAD can potentially be cleared following intra-
tumoral application [12,13]. But even in the absence of an
antiviral immune response, adenoviruses failed to eradicate
established xenograft tumors, despite ongoing viral replication
[10,11]. Spatial constraints were suggested as the major reason for
this dilemma but there are still no satisfactory explanations for the
lack of clinical success with oncolytic adenovirus.
The production of fiber protein molecules in great excess to the
actual need for adenoviral particle assembly has been detected in
the life cycle of several adenovirus serotypes [14–16]. The function
of excessive fiber production is unclear, but it has been suggested
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Another role for the fiber can be in propagation of infection. Ad5
fiber molecules can disrupt CAR-mediated cell-cell adhesion
between airway epithelial cells thereby facilitating and increasing
adenovirus spread across epithelial cell layers, which led to the
hypothesis that an important function of excessively produced
fiber molecules was to increase progeny adenovirus spread from
infected cells to non-infected bystander cells [17]. We have
investigated the role of fiber overproduction in the course of
multiple rounds of CRAD or wild type (WT) adenovirus infection.
We show that fiber overproduction in the few initially infected cells
and their secretion prior to CRAD release results in receptor
masking in the bulk of non-infected neighboring cells, thereby
limiting infection efficiency of progeny CRAD viruses. This
process represents a key detrimental feature limiting CRAD
cancer cell killing efficiency. We observed the fiber overproduction
and its resulting receptor masking during infection by both CAR-
and CD46-binding WT adenoviruses, suggesting that the fiber
overproduction and the tropism-specific receptor masking criti-
cally controls adenovirus propagation and persistency of infection.
Results
Cancer Cell Killing Effect of CRAD Infection at Low MOI
Assuming that CRADs have an exponential propagation
capacity, any permissive cancer cell culture should show an
exponential increase in infected cells following initial round of
CRAD infect-release-reinfect cycles, even when the infection is
initiated in a few cells. To simulate such hypothetical conditions,
we used two CRADs, Ad5-hTERT-E1A-GFP and Ad5F35-
hTERT-E1A (hereafter referred to as Ad5-CRAD and Ad5F35-
CRAD, respectively), to infect cancer cells at very low MOI. In
these two CRADs, the expression of E1A is controlled by the
human telomerase reverse transcriptase (hTERT) promoter, which is
preferentially active in most tumor cells [5]. When adenocarcino-
ma lung cancer A549 cells were infected with Ad5-CRAD or
Ad5F35-CRAD at MOIs of 0.01, 0.1 and 1.0, a significant
reduction in cell numbers at one week post infection was only
observed in infections at a MOI of 1.0, but not at 0.1 or 0.01
(Figure 1). However, the latter cultures were destroyed in the third
or fourth week post infection, demonstrating very slow kinetics of
cell killing. Similar findings were observed in lung cancer HT1080,
and colon cancer Lovo, SW480 cells (Figure 1). These CRADs
indeed propagate (see data below) and super-infection with these
CRADs at a MOI of 10 resulted in complete killing of A549 cell
culture after 3 days. These data indicate that the spread of CRAD
infection is hindered by a hitherto unknown mechanism, and this
mechanism prolongs the co-existence between CRAD propagation
and cell survival in culture.
Tropism-Specific Decrease in Receptor Detectibility in
Infected and Non-Infected Cells
The initiation of adenoviral infection in most cell types is
critically dependent on binding of adenoviral particle fiber to host
cell receptors. Ad5-CRAD binds CAR as a cellular receptor [18],
whereas Ad5F35-CRAD contains the knob and shaft domains of
Ad35 fiber gene and thus utilizes CD46 as a receptor [9]. Of note,
the GFP cDNA is engineered into the E1B locus in Ad5-CRAD
[6], such that CRAD replication can be directly traced in living
cells via GFP expression. Using flow cytometry analysis, we
assessed CAR and CD46 intensity in A549 cultures following
infection with Ad5-CRAD or Ad5F35-CRAD vector at low MOI.
At one week post infection with Ad5-CRAD, CAR was
undetectable in both GFP
+ cells (with viral replication) and GFP
-
cells (without viral replication) as assessed with RmcB mAb
(Figure 2A). In contrast, no measurable decrease of CD46 intensity
was observed as assessed with E4.3 anti-CD46 mAb. Conversely, a
decrease of up to 50% in CD46 intensity, but no obvious effect on
CAR intensity, was observed in cultures following infection with
Ad5F35-CRAD (Figure 2B). Thus, the decrease in receptor
intensity is tropism-specific, and this is unlikely a consequence of
global inhibition of gene expression due to adenovirus infection.
Following Ad5-CRAD infection, an inverse correlation between
the percentages of GFP
+ cells and the relative CAR intensity was
Figure 1. Cancer cell killing of CRAD infection at low MOI. Mean
6 SD (n=3) of total cell numbers of CRAD infected cell cultures relative
to non-infected control cultures at one-week post infection are shown.
doi:10.1371/journal.pone.0008484.g001
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PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8484Figure 2. Decrease of receptor detectibility following CRAD replication in a small fraction of cells. (A) GFP expression and CAR, CD46
intensity in A549 cells at one week following Ad5-CRAD infection at indicated MOI. Numbers in each quadrate represent the phenotypic distribution
of the cells according to GFP expression and CD46 or CAR mAb staining intensity. The numbers in brackets represent the mean fluorescence intensity
(MFI) of CAR or CD46 staining of all cells. Data are representative for (C). (B) CAR and CD46 intensity in A549 cells at one week following Ad5F35-CRAD
infection. The numbers in brackets represent the MFI of CAR or CD46 staining (red line in each histogram) of all cells. The blue lines represent isostype
control antibody staining. (C) Inverse correlation between CAR intensity and the percentages of GFP
+ cells following Ad5-CRAD infection at low MOIs.
Each dot represents one independent assay for GFP expression and CAR MFI relative to the control non-infected cells. (D) The ratios of CAR or CD46
mRNA expression level (filled box, mean 6 SD) and its 95% confidence intervals between Ad5-CRAD infected (with ,2% GFP
+ cells) and non-infected
A549 cultures. (E) Representative CLSM analyses of RcmB binding in A549 control culture (left panel) or cultures at day 6 post infection with Ad5-
CRAD at a MOI of 1.0 with ,1.5% cells being GFP
+ (right panel).
doi:10.1371/journal.pone.0008484.g002
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1% of the cells resulted in a ,50% decrease of CAR intensity in all
cells, and a further decrease close to the background level was
observed when 10% of the cells were infected (Figures 2A and 2C).
And, no decrease in CAR expression, as assessed by CAR mRNA
copy numbers, was detected in Ad5-CRAD infected A549 cultures
(with ,2% GFP
+ cells) compared to non-infected cultures
(Figure 2D). Furthermore, an analogous dose-dependent, tro-
pism-specific decrease of CAR and CD46 intensity was detected in
A549 cells following infection with WT Ad5 and Ad11,
respectively (see below). We performed confocal laser scanning
microscopy (CLSM) analysis to visualize RmcB mAb binding to
individual cells in Ad5-CRAD infected culture. Although a
quantitative measurement was not feasible, compared to non-
infected cultures (Figure 2E, left), a relatively weaker RmcB
binding was generally appreciated in Ad5-CRAD infected cultures
(Figure 2E, right). These findings together demonstrate that
CRAD infection of a small population of cancer cells resulted in
diminished receptor intensity in both infected and non-infected
bystander cells in a tropism specific manner.
Excessive Fiber Molecule Production from the First
Round of CRAD Infected Cells Mask Adenoviral Receptors
To investigate the mechanisms of diminished receptor intensity,
we tested the hypothesis that the initial round of CRAD infection
in few cancer cells produced excessive amounts of free fiber
molecules, which bound to receptors in both infected and non-
infected cells, and thereby masked these receptors. Using 4D2
mAb, previously reported to recognize fiber tail domain of Ad2
and Ad5 [15,19], we studied the effect of fiber production on
receptor intensity in the course of CRAD infection. Following
infection of A549 cell cultures with Ad5-CRAD at a MOI of 0.1,
we observed a progressive increase of fiber binding to GFP
+ as well
as GFP
2 cells from day 3 to 7 post infection (Figure 3A). By day 3
post infection, 76% of the cells had bound fibers whereas only
,1% of the cells were infected by CRAD; by day 5, the binding
had increased to 94% whereas only ,4% of the cells being
infected. Similar findings were also observed when the anti-fiber
mAb clone 2A6, which recognizes the N-terminal half of trimeric
fiber shaft domain was used (data not shown). Concomitantly, a
progressive decrease in CAR intensity (from 72% of the control on
day 3, to 31% on day 5, to non-detectable on day 7), but not of
CD46 was seen (Figure 3A). Similar trends of increasing fiber
binding and decreasing CAR intensity were observed in HT1080,
Lovo, SW480, and breast cancer SK-Br-3 cells following Ad5-
CRAD infection (Figure S1).
Excessive fiber molecules were also detected in the supernatant
of CRAD infected cultures. High intensity fiber binding with
concomitant decrease of CAR intensity was observed when A549
cells were incubated with the supernatants from Ad5-CRAD
infected cultures, irrespective of whether the experiments were
performed at 37uC (permissive for receptor mediated internaliza-
tion) (Figure 3B) or at 0uC (non-permissive for receptor mediated
internalization) (data not shown).
Supernatants from Ad5-CRAD infected cultures can contain
free fiber molecules, as well as large amounts of defective viral
particles and penton complexes with intact fiber. To substantiate
the binding of free fiber molecules to receptors, a supernatant
fraction containing free trimeric fiber molecules (,200 kilodalton
(KDa)) was prepared by depletion of viral particles with
centrifugation at 108 000 g for 1 hr followed by filteration
through a membrane with cut-off size 300 KDa. The free fiber-
containing fraction (,300 KDa fraction) was found to confer a
high intensity fiber binding with a concomitant decrease in CAR
detectability in fresh A549 cells (Figure 3C). The same findings
were also observed with the .300 KDa fraction, which besides
free fiber also likely contained viral particle non-associated penton
complexes [20]. Under standard cell culture conditions, fiber
binding lasted for at least 12 hr (Figure S2). To verify the
specificity of fiber binding, we demonstrated that fiber molecules
from the supernatants of Ad5-CRAD infected A549 cell cultures
bound to CHO cells stably transfected with CAR cDNA, but not
to the mock transfectants (Figure 3D). Furthermore, recombinant
Ad5 fiber knob molecules, but not Ad35 fiber knob molecules,
inhibited the binding of supernatant fiber molecules from Ad5-
CRAD infected cultures to fresh A549 cells. Conversely, Ad35
fiber knob molecules, but not Ad5 fiber knob molecules, strongly
inhibited the binding of supernatant fiber from Ad5F35-CRAD
infected cultures to A549 cells (Figure 3E).
To clarify whether decreased CAR intensity as assessed with
RmcB mAb was due to fiber mediated receptor masking or to a
down-regulated CAR expression, we used polyclonal CAR 72 [21]
antibodies in combination with CLSM analysis to detect and
visualize the localization of CAR molecules in A549 cells at day 6
following Ad5-CRAD infection at a MOI of 1.0. A patchy
distribution of cell surface CAR staining as shown in Figure 2E
was also detected with CAR 72 in non-infected cultures. In Ad5-
CRAD infected cultures (with ,1% GFP
+ cells), the same CAR
localization pattern as in the non-infected cultures was detected
(Figure 4, upper left panel). Cell surface fiber binding was detected
in a great majority of the cells, irrespective of the level of GFP or
hexon expression (Figures 4, upper right panel and Figure S3).
Importantly, vast majority of CAR and fiber labeling was co-
localized as shown in the merged staining patterns (Figure 4, lower
right panel and Figure S4). CAR and fiber internalization from
cell surface were insignificant, as also shown in studies when A549
cells were incubated at 37uC with the supernatants of A549 cell
cultures previously infected with Ad5-CRAD (Figure S5).
Collectively, these findings demonstrate that fiber molecules
produced from the few initially infected cells mask CAR on both
CRAD infected and non-infected bystander cells.
Mechanisms of Fiber Overproduction during Adenovirus
Life Cycle
Next, we characterized the kinetics of fiber binding to CAR
during WT Ad5 or Ad5-CRAD life cycle. A549 and 293 cells were
super-infected with WT Ad5 or Ad5-CRAD at a MOI of 5 or 50.
Cell surface fiber binding was assessed at 12, 16, 20 and 24 hr post
infection. The kinetics of fiber release was comparable between WT
Ad5 and Ad5-CRAD infected cells (Figure 5A). Analogous results
were obtained also with 293 cells. Cell surface fiber binding was
readily detected 20 hr after infection with both WT Ad5 and Ad5-
CRAD at a MOIof5.At24 hrpost infection,a high density offiber
binding was detected on all cells. Concomitantly, a 5-fold
diminished CAR intensity as assessed by RmcB mAb was detected
(data not shown). Similar fiber intensities were detected on GFP
+
and GFP
2 cells, suggesting that fibers secreted from cells with
replicating virus spread to cells lacking the replicating virus. At
20 hr post infection, the vast majority of the viral particles were still
intracellular (ratio to extracellular virus particles was 10
4:1). Thus,
much adenoviral fiber protein is secreted prior to viral particle
release. Further, the supernatants of A549 cells following super-
infection with WT Ad5 were collected at 24, 48 and 72 hr post
infection and assessed for the content of fiber molecules following
depletion of cells. Increasing intensity of the monomer fiber band at
,50 000 Da was detected in supernatants harvested at 48 and
72 hr post infection (Figure 5B), suggesting that large amounts of
fiber molecules are also released after the infected cells are killed.
Adenovirus Receptor Masking
PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8484Figure 3. Fiber binding and receptor masking in infected and non-infected cells. (A) Progressive fiber binding and concomitant decrease in
CAR intensity in both infected and non-infected A549 cells were similar following infection with Ad5-CRAD at low MOI. Representative data from 3
independent studies are shown. (B) Supernatants from Ad5-CRAD infected A549 cultures conferred cell surface fiber binding and concomitant
decrease in CAR intensity in non-infected A549 cells. Non-infected cells were incubated for 2 hr with A549 culture supernatants harvested at one
week post infection with Ad5-CRAD at the indicated MOI, washed and analyzed for CAR and fiber intensity. Data shown are representative histograms
of 3 experiments performed at 37uC. The MFIs of isotype control (blue lines), CAR (red lines) and fiber (black lines) staining of all cells are indicated at
the right part of each histogram. (C) Free fiber molecules in ,300 KDa supernatant fraction from Ad5-CRAD infected A549 cultures conferred the
same effect as in (B). Supernatants used in (B) were centrifuged at 108 000 g for 1 hr, fractioned through a membrane with 300 KDa cut-off, and
subsequently used in binding experiments as in (B). (D) Supernatants from A549 cell cultures at one week following infection with Ad5-CRAD at the
indicated MOIs conferred fiber binding only to CAR expressing CHO cells. The mean 6 SD (n=2) of fiber binding MFI are shown. (E) Supernatant fiber
binding to fresh A549 cells was inhibited by recombinant Ad5 or Ad35 fiber knob molecules in a tropism specific manner. The mean 6 SD (n=2) of
fiber binding MFI to A549 cells are shown.
doi:10.1371/journal.pone.0008484.g003
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production, we used real-time RT-PCR to quantify the mRNA
transcripts encoding adenoviral structural proteins at 20 hr post
infection. With the hexon mRNA copy numbers as reference, the
fiber to hexon and penton to hexon ratios were 0.9760.17 and
0.4960.14, respectively (N=6, p,0.00001, paired t test)
(Figure 5C). Thus, extremely significantly more fiber mRNAs
were produced compared to penton base mRNAs. These data
suggest that fiber over-production, and the relative ratio between
fiber and penton base overproduction [15], appear to be a direct
consequence of the transcript abundance.
We further investigated whether fiber mediated receptor
masking is a general mechanism in adenovirus infection. The 51
adenovirus serotypes are divided into species A to F. While
serotypes of species A, C, D, E and F bind CAR as a receptor [22],
most B species adenoviruses bind CD46 [23–25]. High intensities
of cell surface fiber binding were detected in A549 cells following
CD46-binding species B Ad11 and Ad35 infection (Figure 5D). To
these fiber bound cells, we used three different clones of anti-CD46
mAb, E4.3, J4.48 and also the CD46 blocking clone MEM-258
[25], to detect CD46 intensity. The binding of E4.3 and J4.48
clone was comparably diminished (J4.48 binding data not shown).
However, a binding capacity at 10 to 20% of the control non-
infected cells showed that MEM-258 binding was inhibited most in
Ad11 and Ad35 fiber bound cells (Figure 5D). Since a down-
regulated CD46 expression would have reduced the binding
capacity of all 3 anti-CD46 mAbs to the same extent, these
findings strongly suggest that CD46 is masked during infection
with Ad11 and Ad35. In addition, we also studied the eventual
receptor masking following infection of A549 cells with Ad31
(species A), Ad3 and Ad7 (species B), Ad37 (species D) and Ad4
(species E). Ad41 (species F) was not included in the analysis
because we failed to obtain successful replication in this fastidious
serotype. Under our conditions, we detected significantly dimin-
ished CAR intensity following Ad4, Ad5 and Ad37 infection in
A549 cells (Figure 5D). Cell surface fiber binding was not detected
following Ad4 infection, suggesting that the 4D2 mAb may not
recognize Ad4 fiber molecules. Consistent with previous observa-
tions that Ad37 fiber can bind to both CAR and CD46 [26,27], we
now found that both CAR and CD46 were masked following
Ad37 infection, but not to same extent as when infected with Ad11
and Ad35 (CD46) or Ad4 and Ad5 (CAR), which is in agreement
with our previous report of Ad37 using sialic acid as a receptor
[28]. However, measurable decrease of CAR or CD46 intensity
were not detected in A549 cells following infection with Ad31, Ad3
and Ad7, suggesting that these serotypes may use either other
molecules as main receptors, or not produce excessive amounts of
fiber molecules, or both. Together, these data suggest that fiber
mediated receptor masking is a shared mechanism during
infection of CAR- or CD46-binding adenovirus serotypes.
Effect of Fiber Overproduction and Its Secretion on CRAD
Functionality
To investigate the effect of fiber mediated receptor masking on
efficiency of CRAD infection, A549 cells were first infected with
Ad5-CRAD at a MOI of 1.0. Six days later, cells were further
super-infected with replication defective Ad5-PGK-GFP. The
frequencies of GFP expressing cells were measured 24 hr later.
Because Ad5-CRAD also encodes GFP, more GFP
+ cells would be
expected in cultures infected with Ad5-CRAD and Ad5-PGK-
GFP compared to the parallel control cultures infected only with
Ad5-PGK-GFP. In contrast, the percentages of GFP
+ cells in Ad5-
CRAD infected cultures were only 60% of the control cultures
without prior Ad5-CRAD infection (Figure 6A). Concordantly,
cells from day 6 Ad5-CRAD infected cultures showed a CAR
intensity correlated decrease in their binding capacity to
35S
labeled WT Ad5 (Figure 6B). These data demonstrate that CRAD
binding to and infection of receptor masked cancer cells can be
significantly diminished.
The supernatants of Ad5-CRAD infected cultures contained
both free fiber molecules and progeny CRADs. To assess the net
supernatant effect in CRAD infection, we first incubated A549
cells at 37uC for 2 hr with the supernatants from A549 cell cultures
that had been previously infected with Ad5-CRAD. Subsequently,
cells were super-infected with Ad5-PGK-GFP or Ad5F35-PGK-
GFP at a MOI of 10. Compared to cells incubated with the
control supernatants from non-infected cultures, the supernatants
from Ad5-CRAD infected cultures conferred an up to 50%
reduction of the infectivity of CAR-binding Ad5-PGK-GFP; but
the infectivity of CD46-binding Ad5F35-PGK-GFP was not
affected (Figure 6C). These data further substantiate the
conclusion that fiber overproduction and its resulting receptor
masking of bystander cells hinder efficient CRAD infection.
To study whether the consequences of fiber overproduction are
operational in vivo, a single intra-tumoral injection of 1610
9 plaque
forming unit (PFU) hTERT promoter controlled CNHK500
CRAD [7] particles was performed with A549 cell xenografts in
mice. Adenoviral hexon and fiber proteins were immunohisto-
chemically localized in the tumors at day 3, 7 or 10 post injection.
As shown by the localization of hexon expression, CRAD
propagated within restricted regions in tumor (Figure 7). We
consistently observed broader and more intense fiber staining
compared to hexon staining in tumors at day 7 or 10 post CRAD
injection. Similar findings of extensive fiber production were also
observed in CNHK500 treatment of a liver carcinoma xenograft
model (data not shown). These findings show that fiber molecules
Figure 4. CLSM analysis of cell surface CAR expression and
fiber binding. A549 cultures at 6 days post infection with Ad5-CRAD
at a MOI of 1.0 were co-stained for cell surface CAR expression with the
polyclonal rabbit anti-CAR 72 antibody (upper left) and fiber binding
with mAb 4D2 (upper right) and analyzed in CLSM. The merged images
(lower right) demonstrate the co-localization (white) of CAR and fiber
molecules on cell surface.
doi:10.1371/journal.pone.0008484.g004
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8484Figure 5. Mechanisms of fiber production during adenovirus life cycle. (A) Fiber secretion prior to adenoviral particle release. A549 cells
were infected with WT Ad5 or Ad5-CRAD at a MOI of 50, cell surface fiber binding and GFP expression were assessed at the indicated time points post
infection. Data are representative for A549 cell infection experiments. (B) Release of fiber upon cell lysis. A549 cells were infected with WT Ad5 at a
MOI of 10 in DMEM containing 2% FCS. Forty mg of supernatant proteins harvested from the control non-infected culture, or from infected cultures at
24, 48 and 72 hr post infection were analyzed in Western-blot with 4D2 anti fiber mAb. (C) Abundance of fiber mRNA in Ad5 life cycle. Total RNA was
extracted from A549 cells at 20 hr post infection with WT Ad5 or Ad5-CRAD as in (A), and analyzed for fiber, penton and hexon mRNA copy numbers
in real-time RT-PCR. The paired ratios of fiber to hexon (F:H) and penton to hexon (P:H) mRNA copy numbers from each infection are depicted. (D)
Fiber overproduction and receptor masking of various adenovirus serotypes. A549 cells were infected with indicated WT adenoviruses at 500 (Ad31,
Ad3, and Ad37), 50 (Ad4), or 10 (Ad11, Ad35 and Ad5) viral particles per cell. Cell surface fiber binding and receptor intensity were analyzed upon
visible CPE or day 10 post infection. In each histogram, the red and blue lines represent staining with infected and non-infected control cultures,
respectively.
doi:10.1371/journal.pone.0008484.g005
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PLoS ONE | www.plosone.org 7 December 2009 | Volume 4 | Issue 12 | e8484Figure 6. Consequences of fiber mediated receptor masking for CRAD infection. (A) Infectivity of receptor masked A549 cells by adenoviral
vectors. A549 culture was first infected with Ad5-CRAD at a MOI 1.0. Six days later, cells were further infected with Ad5-PGK-GFP at a MOI of 10 and
GFP expression was assessed 24 hr later. Data shown are the relative mean 6 SD (n=3) of the percentages of GFP
+ cells in cultures infected by both
Ad5-CRAD and Ad5-PGK-GFP compared to control cultures infected by Ad5-PGK-GFP only. (B) Adenovirus binding capacity to receptor masked cells.
CAR intensity and
35S-Ad5 binding capacity to cells of A549 culture at day 6 post Ad5-CRAD infection (MOI =1.0) relative to cells of non-infected
control culture of three independent experiments are shown. (C) Supernatants from Ad5-CRAD infected A549 cells conferred tropism-specific low
infectivity to fresh A549 cells. A549 cell cultures were first incubated with supernatants of Ad5-CRAD infected cultures as in Figure 3B. Following
extensive washing, cells were further infected with Ad5-PGK-GFP or Ad5F35-PGK-GFP at a MOI of 10. GFP expression was measured 24 hr later. The
mean 6 SD (n=3) of the percentages of GFP
+ cells are shown. The percentages of GFP
+ cells in cultures incubated with the indicated Ad5-CRAD
infection supernatant alone were deducted from the values presented in the grey or black bars.
doi:10.1371/journal.pone.0008484.g006
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strongly suggest that also in vivo fiber overproduction can limit
CRAD progeny infection of bystander cells.
Discussion
Our study reveals that during Ad5 based CRAD infection, large
amounts of fiber molecules are secreted from cells prior to viral
particle release. Fiber molecules produced from just 1 to 2% of
cancer cells being CRAD infected are sufficient to mask adenoviral
receptors in the bulk non-infected bystander cells. This receptor
masking hinders CRAD progeny infectivity in bystander cells. We
also reveal that fiber mediated receptor masking is a shared feature
among CAR- or CD46-binding serotypes of adenoviruses. Our
findings have fundamental implications for CRAD development
and also provide a framework for understanding basic mechanisms
underlying the natural course of adenovirus propagation.
Although CRAD can be fiber re-targeted to more efficiently
target and infect different types of cancer cells, and CRAD
replication can be stringently engineered in a cancer cell-specific
manner, the capacity of CRAD mediated cancer cell killing has
been limited. This is reflected in a large body of studies which
show that up to 1610
9 and 1610
12 viral particles are frequently
applied in xenograft cancer therapy models and clinical trials,
respectively [4,6,7]. CRAD cancer therapy in xenograft models
was shown to inhibit cancer growth, but did not eradicate cancer
[10,11], and only marginal cancer therapy effects were observed in
clinical trials [4]. The CRAD cancer cell killing capacity is
dependent not only on the efficiency of CRAD replication, but
also on the efficiency of progeny CRAD dispersal and propagation
of infection within cancer tissue. However, the very first round of
CRAD replication in a small fraction of cancer cells can already
result in adenovirus receptor masking in the not yet infected
bystander cancer cells. Consequently, receptor masked cancer cells
cannot be efficiently infected by progeny CRADs when these are
eventually released upon cell lysis. In the course of multiple rounds
of CRAD infection, non-infected cancer cells proliferate and can
also become receptor masked. Receptor masked cancer cells, when
not infected by CRAD, may also proliferate (Figure 8). Due to
higher binding avidity (combined strength of multiple bond
interactions) between progeny viral particles and receptors
compared to the binding between free fiber molecules and
receptors, receptor masked bystander cells are bound and infected
by CRAD progenies at low efficiency. The net therapeutic effect of
CRAD will be dependent on the outcome between cancer cell
proliferation and CRAD mediated cell killing. For CRAD to be
efficient in cancer cell killing, fiber mediated receptor masking
needs to be counteracted. In addition to overcoming the hurdle of
neutralizing immunity [12,13], it can be envisaged that non-Ad5
based CRADs, or Ad5 based CRADs engineered to express and
secrete less fiber molecules would propagate more efficiently and
have a more potent oncolytic capacity.
Fiber molecules associated with the adenovirus particle have
been demonstrated to be important for adenovirus particle
Figure 7. Extensive fiber production during CRAD treatment of xenograft tumors. Following a single intratumoral injection of 1610
9 PFU
CNHK500, A549 cell xenograft tumors were dissected at day 3, 7 and 10 post injection and consecutive sections were stained for fiber and hexon
proteins. Representative staining of fiber and hexon proteins are shown (6200).
doi:10.1371/journal.pone.0008484.g007
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intracellular trafficking routes of internalized particles [15,29].
In the life cycle of several adenovirus serotypes, fiber and to a
less extent penton base molecules are overproduced [14–16].
Penton base as well as penton can form dodecahedra [20]. The
function of the free fiber molecules and dodecahedra has been
elusive. Previous studies have demonstrated a role for Ad5 fiber
molecules in disrupting CAR-mediated inter-epithelial cell-cell
adhesion which could facilitate adenovirus spread in the course
of a natural infection process [17]. However, our study strongly
suggests that the functional consequence of fiber overproduction
is unlikely to be restricted to disrupting CAR-mediated cell-cell
adhesion [17]. Besides CAR binding Ad5, Ad4 and Ad37, fiber
mediated receptor masking was also detected during infection
with CD46 binding Ad11 and Ad35 under our conditions.
Unlike CAR, CD46 does not form inter-epithelial cell
homodimers that contributes to upholding tight junctions and
epithelial integrity. Although it is possible that some adenovirus
serotypes (e.g. Ad3 and Ad7) utilize cell surface receptors other
than CAR and CD46 [25,30], and the possibility also exists that
the antibodies used in this study did not detect the fiber
molecules of the remaining seroty p e s ,o rt h e s ef i b e rm o l e c u l e s
bind to CAR with a lower affinity, our data strongly suggest that
fiber mediated receptor masking in bystander cells is a
conserved, fundamental mechanism for the adenovirus-host cell
interaction, which is likely a critical modulator of adenovirus
propagation.
There are significant differences in the pathogenicity and
course of disease among different serotypes, and infection of
certain serotypes can persist for years in immune competent
individuals [1,4,31]. Host cells when infected with adenovirus,
activate host-antiviral defense mechanisms, such as the produc-
tion of interferon molecules and inflammatory cytokines [32].
Adenoviruses on the other hand are endowed with counter-
offense capacities against such cellular antiviral defense. E1A and
E1B products for example, can suppress the transcription of
interferon-stimulated genes, and E3 19 k proteins can inhibit
cell-surface expression of HLA class I molecules [33]. These
counter-offense mechanisms may protect adenovirus-infected
cells from attack by innate and adaptive immune responses and
thereby contributes to adenovirus persistency. However, these
virus host cell interaction mechanisms are restricted to the
survival of adenovirus-infected cells. Using CRAD also encoding
for GFP, we can distinguish cells with adenovirus replication from
those without, and assess what consequence a small population of
infected cells can have on the surrounding non-infected cells. Our
data have demonstrated that adenovirus infection in a small
fraction of cells can result in receptor masking in the bulk of non-
infected bystander cells (illustrated in Figure 8). Fiber mediated
receptor masking provides a relative ‘‘protection’’ from progeny
virus infection to the non-infected bystander cells. This can be
advantageous to adenovirus propagation and persistency as
compared to immediate killing of all host cells following infection.
Instead, adenoviruses benefit from a co-existence between virus
and host cells, with a lower rate of viral production compared to
the acute infection phase. In this context, we hypothesize that the
extent of fiber overproduction and secretion could serve as a
virulence factor for different adenoviruses. In agreement with this
hypothesis, persistent clinical infections have been observed by
Ad4, Ad5, Ad11 and Ad35 [1,31,34,35], the serotypes demon-
strated to be capable of causing fiber overproduction and
receptor masking in this study.
Our findings of excessive production of viral attachment
proteins such as fiber in the few initially infected cells, and the
resulting receptor masking in the bulk of non-infected bystander
cells are unlikely unique to adenoviruses. Excessive production
of defective viral particles and attachment proteins are common
during natural infection with various types of viruses. It can be
envisaged that attachment protein overproduction in infected
cells and the resulting viral receptor modulation in non-infected
bystander cells is a frequent phenomenon during viral infection.
In fact, adenovirus receptors CAR, sialic acids and CD46 are
also utilized as host cell receptors for other types of viruses. For
example, CD46 is utilized as a receptor by vaccine strains of
measles virus, human herpes virus type 6 (HHV-6) and bovine
viral diarrhoea virus [36], and sialic acid is a receptor for
influenza viruses [37]. As an integral member of tight junction,
CAR is structurally and functionally similar to other cell
adhesion receptors, such as CD155 for polioviruses, junction
adhesion molecule for reoviruses, and nectins for herpes simplex
viruses [38]. Interestingly, the reovirus attachment protein s1i s
structurally similar to adenovirus fiber molecules [39]. And, s1
proteins from reovirus type 1 and type 3 determine the pattern
of reovirus spread from the initial infection site to the central
nervous system [40]. Although the eventual overproduction of
a t t a c h m e n tp r o t e i ni ni n f e c t e d cells and the resulting viral
receptor modulation in non-infected bystander cells remain to
be investigated for these viruses, receptor down-modulation or
masking may inhibit superinfection of host cells by progeny
virus, or facilitate virus escape from infection site to the
secondary organs or tissues, or enhance cell sensitivity to
antibody mediated cell killing. Thus, overproduction of viral
attachment molecules and its resulting modulation of viral
receptors may contribute to control the natural infection course
of various viruses.
In summary, our studies demonstrate a fundamentally detri-
mental role of fiber overproduction in CRAD functionality, and
strongly suggest fiber overproduction and its resulting receptor
masking as a key factor contributing to adenovirus host co-
existence. These findings have fundamental implications for the
development of antiviral strategies and human gene therapy.
Figure 8. Effects of fiber overproduction and its resulting
masking in CRAD cancer therapy and adenovirus propagation.
The initially infected cells secrete large amounts of fiber molecules prior
to progeny virus release. Consequently, the receptors on bystander cells
are masked by fiber molecules (red). Receptor masked cells cannot be
efficiently infected by progeny viruses (blue) when these are released
upon cell lysis. This mechanism inhibits CRAD cell killing effects, but
promotes a prolonged adenovirus host co-existence.
doi:10.1371/journal.pone.0008484.g008
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Viruses
Ad5-CRAD and Ad5-PGK-GFP have been previous described
[6,9]. In the Ad5-CRAD, the E1 sequences from Ad5 nucleotides
458 to 3533 are engineered downstream of the hTERT promoter,
and the GFP cDNA is engineered downstream of E1B using the
internal ribosomal entry site sequence [6]. The Ad5F35-CRAD
was generated using a modified AdEasy system [9]. Briefly, an
E1A encoding expression cassette controlled by hTERT promoter
and rabbit b-globin intron 2 and polyA sequences was engineered
into pShuttle, and inserted into pAdEasy1/F35 via homologous
recombination in E coli BJ5183 strain [5,9]. The E3 region is
deleted in both Ad5-CRAD and Ad5F35-CRAD. Viruses were
rescued in 293 cells according to standard procedures [9]. WT
viruses were expanded in A549 cells. All recombinant viruses and
WT viruses were purified with the two-step CsCl centrifugation
procedure. Physical particle titer was measured at OD260 [41]
and the titer of infectious units (IU) was determined using Adeno-
X rapid titer kit (Clontech). The viral preparations have a physical
particle to IU ratio of 10:1. MOIs are in IUs/cell.
Cell Culture and Adenovirus Infection
CHO-CAR and CHO-control cells were cultured with MEM-
alpha medium-nucleotides supplemented with 5% heat inactivated
dialyzed fetal calf serum (FCS), 100 U/ml penicillin, and 100 mg/
ml streptomycin. A549, HT1080, LoVo, SW480 and SKBr3 cells
were cultured in DMEM supplemented with 10% heat inactivated
FCS, 1% non-essential amino acids, 100 U/ml penicillin, and
100 mg/ml streptomycin. Cells were seeded at 12 000 cells/well in
12-well plates and infected with CRAD after 2 hr of culture. To
assess cell killing, living cells in each well determined by trypan
blue exclusion were counted at day 7 post infection.
Flow Cytometry Analysis
Fiber binding and receptor intensity in CRAD or WT Ad
infected cultures were assessed at the indicated days post infection,
or at the appearance of CPE, or latest at day 10 post adenovirus
infection. Antibody staining procedures were performed on ice.
Cells were first incubated with either anti-CAR or anti-CD46, or
isotype-matched control mAb for 15 min. Following PBS washing,
cells were incubated with Alexa FluorH 647 conjugated goat anti-
mouse IgG antibody (Molecular Probes) for 15 min. Finally, cells
were washed and resuspened in PBS containing 1 mg/ml 7-
aminoactinomycin D (7-AAD, Sigma). Living cells negatively
stained with 7-AAD were analyzed. We used clone RmcB
(Upstate) and E1-1 (Abcam) anti-CAR mAbs; clone E4.3 (BD),
MEM-258 (BioLegend), and J4.48 (Chemicon) anti-CD46 mAbs.
The anti fiber mAbs (clone 4D2 and 2D6) were from GeneTex.
MOPC-21 (IgG1, Sigma) and MG2a00 (IgG2a, CALTAG
Laboratories) served as isotype controls.
Preparation of Free Fiber Containing Supernatant and
Endogenous Fiber Blocking Assay
Supernatants were harvested from control or Ad5-CRAD
infected A549 cultures at day 7 post infection, filtered through a
0.22 mM sterile filter (Sarstedt). When free fiber containing
supernatants were used, supernatants were first spun twice at
108 000 g for 1 hr, filtered through a Jumbosep
TM centrifuge
device with a 300 kDa cut-off (Pall Corporation) and followed by
the 0.22 mM sterile filter. A549 cells, CHO-CAR and CHO-
control transfectants were seeded in 24-well plates at 10
5 cells/
well. After 24 hr of culture, 0.5 mL supernatants from control or
Ad5-CRAD infected A549 cultures were added and cells were
incubated for 2 hr at 37uC. Following twice PBS washing, cells
were either directly analyzed in flow cytometry for fiber binding
and receptor intensity, or infected with Ad5-PGK-GFP at a MOI
of 10. GFP expression was analyzed 24 hr later.
In some experiments, seeded A549 cells were first incubated for
2h ra t3 7 uC with 2 mg/ml recombinant Ad5 or Ad35 fiber knob
molecules [42]. Following 2x PBS washing, 0.5 mL supernatant
from Ad5-CRAD or Ad5F35-CRAD infected cultures were
added, and cells were further incubated for 2 hr at 37uC. Finally,
cell surface binding of endogenous fiber, but not the knob
molecules, was detected with 4D2 mAb in flow cytometry.
Western-Blot Analysis
A549 cells were infected with WT Ad5 at a MOI of 10 in
DMEM containing 2% FCS. Supernatants were harvested at 24,
48 and 72 hr post infection. Following depletion of cells at 4 000 g
for 10 min, a cocktail of protease inhibitors (Sigma, p-2714) was
added to one tenth of the supernatant volume. Forty mgo f
supernatant proteins were separated with SDS-PAGE and
transferred to PVDF membrane. Following blocking with 5%
BSA and 0.5% goat serum, the membrane was incubated with
1.0 mg/ml 4D2 anti fiber mAb at 4uC overnight. Subsequently,
the membrane was incubated with goat anti-mouse IgG-HPR and
visualized with Opti-4CNTM substrate kit.
Adenovirus Binding and Re-Infection Assay in CRAD
Infected Cultures
A549 cells were infected with Ad5-CRAD at a MOI of 1.0. On
day six post infection, cells were trypsinized and either analyzed for
cell surface CAR intensity using flow cytometry, or assessed in virus
binding assay as described below. Following twice washing in
binding buffer (DMEM, 2 mM MgCl2, 1% BSA and 20 mM
HEPES), cells were resuspended at 2610
5 cells/100 mLa n d
incubated for 20 min on ice. S
35 labelled WT Ad5 viruses were
then added. Following incubation for 1 hr on ice and 2x washing in
binding buffer, cells were pelleted and resuspended in scintillation
fluid. The cell-associated radioactivity was counted with a liquid
scintrillationanalyzer(Tri-Carb2800TR,PerkinElmer).Theday6
Ad5-CRAD infected or uninfected control A549 cultures were re-
infected with Ad5-PGK-GFP at a MOI of 10 and analyzed for GFP
expression 24 hr later using flow cytometry.
CLSM Analysis
A549 cell suspension (10
4 cells/mL) was mixed with dilutions of
Ad5-CRAD at a MOI of 1. The cell/virus mixture was plated
either 0.5 mL/well in 12-well plates or 0.25 mL/well in 8-well m-
slide (IBIDI) and incubated at 37uC. At day 6 post infection,
cultures in 12-well plates were analyzed by flow cytometry for GFP
expression, cell surface fiber binding and CAR intensity. The
parallel cultures in m-slides were prepared for CLSM analysis.
Following washing with PBS, cells were incubated in 5% goat
serum for 20 min, followed by incubation with RmcB mAb
(1:200), or with rabbit polyclonal CAR 72 antibodies (1:500), or
rabbit polyclonal anti Ad5 hexon antibodies (1:1000, Abcam) in
combination with anti fiber 4D2 mAb (1:200) for 90 min. The
slides were then washed and incubated for 30 min with 1:400
diluted goat anti-mouse Alexa FluorH 647, or combined with goat
anti-rabbit Alexa FluorH 568 (Molecular Probes). For antibody
specificity control and adjustment of auto-fluorescence, staining
excluding the primary antibodies was included in every experi-
ment. After rinsing, DAPI (0.1 mM) was added to all wells. All
staining procedures were performed on ice. GFP expression, CAR
and fiber localization were assessed with a Zeiss LSM 510 Meta
microscope.
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supernatants from A549 cultures previously infected with Ad5-
CRAD or directly infected with Ad5-CRAD as described above,
cells were fixed (4% paraformaldehyde for 30 min) and permea-
bilized (0.3% Triton x-100 for 5 min), and subsequently stained
with CAR 72 or anti-hexon and 4D2 antibodies and analyzed in
CSLM as above.
Kinetics of Fiber Secretion and Real-Time RT-PCR
A549 or 293 cells were seeded at 10
5 cells/well in 24-well plates.
Twenty four hr later, cells were infected with Ad5-CRAD or WT
Ad5 at a MOI of 5 or 50. Cell surface fiber binding was analyzed
by flow cytometry at 12, 16, 20 and 24 hr post infection. At 20 hr
post infection, supernatants were saved, cells were detached from
the plate and resuspended in the same volume as the supernatant.
The harvested supernatant and cell fractions were 3x frozen/
thawed, filtered through 0.22 mM sterile filter, and titered in a
standard plaque assay. Cells at 20 hr post infection with Ad5-
CRAD or WT Ad5 as above were also harvested for total RNA
extraction. Total RNA was reverse transcribed and used for real-
time PCR assessment of hexon, penton and fiber mRNA
abundance as detailed in Data S1.
Xenograft Experiment and Immunohistochemistry
Analysis
This study was approved by the ethical committee of Shanghai
Eastern Hepatobiliary Surgical Hospital, and we followed the
criterion in animal experiments established by American Veter-
inary Medical Association to dispose animals scientifically and
humanely [43]. Four weeks old BABL/c-Nude mice were injected
subcutaneously with 1610
7 A549 cells in 100 mL PBS. Three
weeks later, tumors with a diameter of about 5 mm were injected
with 100 mL Ad buffer (10 mmol/L Tris-HCl pH 8.0, 2 mmol/L
MgCl2, and 4% sucrose) containing 1610
9 PFU of CNHK500 [7]
or Ad buffer alone. Five animals were killed on 3, 7, or 10 days
post CRAD injection. Tumors were dissected, fixed in formalin
and embedded in paraffin. Consecutive sections of 5 mm were
prepared and stained with 1:200 diluted mouse anti-hexon
antibody (MAB8052, Chemicon) or anti-fiber 4D2 mAb at 4uC
overnight. Subsequently, sections were stained with biotin-
conjugated goat-anti-mouse antibody and streptavdin-peroxidase
reagents (Maxim Laboratories, Inc), each for 30 min at 37uC.
Following diaminobenzidine development and counterstaining
with hematoxylin, the hexon and fiber staining patterns were
evaluated under a magnification of 6200.
Supporting Information
Data S1
Found at: doi:10.1371/journal.pone.0008484.s001 (0.03 MB
DOC)
Figure S1 Cell surface fiber binding and decrease of CAR
intensity in cancer cell lines following Ad5-CRAD infection.
Concomitant cell surface fiber binding and decrease of CAR
intensity in both infected and non-infected bystander cells at 7
days post infection with Ad5-CRAD are shown. Data are
representative for 3 independent experiments performed with
each cell line.
Found at: doi:10.1371/journal.pone.0008484.s002 (2.16 MB TIF)
Figure S2 Sustained binding of fiber or recombinant knob
molecules to receptors. (A) A549 cells were incubated for 2 hr at
37uC with ,300 KDa supernatant from cultures previous infected
with Ad5-CRAD. Cells were extensively washed, further cultured
for indicated hr at 37uC, and assessed for cell surface fiber binding
and CAR intensity by flow cytometry. The mean and SD (n=3) of
fiber binding MFI and relative CAR intensity are shown. (B) The
mean and SD (n=3) of CAR or CD46 staining intensity relative to
control cells in A549 cells at 48 hr following a 2 hr incubation with
knob molecules are shown.
Found at: doi:10.1371/journal.pone.0008484.s003 (0.50 MB TIF)
Figure S3 CLSM analysis of hexon and fiber on A549 cell
culture previously infected with Ad5-CRAD at low MOI.
Following fixation with paraformaldehyde and permeabilization
with Triton x-100, cells were co-stained with anti-hexon and anti-
fiber antibodies, and subsequently with their corresponding
secondary antibodies. Nuclear staining was performed with DAPI
(upper left). Representative staining of hexon (upper right), GPF
(middle left), and fiber (middle right) show hexon and GFP only in
the infected cell but fiber on the surface of a great majority of the
cells. Merged image is shown in the lower left panel.
Found at: doi:10.1371/journal.pone.0008484.s004 (3.54 MB TIF)
Figure S4 CLSM analysis of cell surface fiber binding and CAR
distribution in A549 cell cultures infected with Ad5-CRAD.
Representative staining patterns of CAR (upper left), fiber (upper
right), GFP (lower left) in the Ad5-CRAD infected A549 cultures
with ,2% GFP+ cells are shown. The merged image (white, lower
right) shows cell surface co-localization of CAR and fiber
molecules. Staining was performed in living cells on ice.
Found at: doi:10.1371/journal.pone.0008484.s005 (0.75 MB TIF)
Figure S5 CLSM analysis of fiber binding and CAR distribution
in A549 cells following incubation with supernatant of A549
culture previously infected with Ad5-CRAD. A549 cells were
incubated with supernatant of A549 culture previously infected
with Ad5-CRAD at 37uC for 2 hr. Following fixation with
paraformaldehyde and permeabilization with Triton x-100, cells
were co-stained with CAR 72 and 4D2 primary antibodies, and
subsequently with their corresponding secondary antibodies.
Represent staining patterns of CAR (upper left), fiber (upper
right), and DAPI (lower left) are shown. The merged image
(yellow, lower right) shows that most fiber molecules co-localized
with CAR on the cell surface.
Found at: doi:10.1371/journal.pone.0008484.s006 (4.22 MB TIF)
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